Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...

Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...

Johnson & Johnson MedTech’s Biosense Webster today announced the launch of the latest version of its Carto 3 heart mapping system.

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTOtm 3 System Version 8, the latest version of the company's ...

In Jan.'93 three group companies -- Ecomax Agro Systems Biosense Corporation Projection and Good Value Marketing -- merged to form GVM.GVM came out with a rights issue in Dec.'94 to part-finance ...

Report Ocean (150+ country’s markets analyzed, function on 1,00000+ published and forthcoming reports every year.] presents a ...

Global Atrial Fibrillation Market generated revenue of US$ 3,310.1 million in 2022 and is estimated to reach a valuation of US$ 6,839.8 million by 2031 at a CAGR of 8.71% during the forecast period, ...